B. Ẑivković

发表

The psychopharmacology of GABA synapses: update 1989.

B. Scatton, P. Morselli, K. Lloyd, 1990, Journal of neural transmission. Supplementum.

B. Scatton, G. Bartholini, B. Zivkovic, 1989 .

Antidopaminergic properties of yohimbine.

B. Scatton, B. Zivkovic, J. Dědek, 1980, The Journal of pharmacology and experimental therapeutics.

Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.

C. Carter, B. Scatton, K. Lloyd, 1990, The Journal of pharmacology and experimental therapeutics.

Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes

G. Perrault, D. Sanger, C. Cohen, 1994, Neuroscience & Biobehavioral Reviews.

Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P.

A. Oblin, G. Bartholini, B. Zivkovic, 1984, European journal of pharmacology.

Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.

G. Perrault, D. Sanger, K. Lloyd, 1986, The Journal of pharmacology and experimental therapeutics.

The gabaergic hypothesis of depression

B. Scatton, P. Morselli, K. Lloyd, 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Origin of 5-Hydroxyindoleacetic Acid in the Spinal Fluid

B. Zivkovic, M. Bulat, B. Ẑivković, 1971, Science.

Antidepressant and potential antimanic actions of GABA receptor agonists

B. Scatton, P. Worms, K. Lloyd, 1983 .

The GABA hypothesis of depression and antidepressant drug action.

B. Scatton, P. Morselli, K. Lloyd, 1985, Psychopharmacology bulletin.

Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence

G. Perrault, D. Sanger, B. Zivkovic, 1993, Neuropharmacology.

Animal Models and Recent Developments in the Search for Novel Anxiolytics

G. Perrault, D. Sanger, B. Zivkovic, 1991 .

Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.

E. Mackenzie, J. Vincent, P. Legendre, 1988, The Journal of pharmacology and experimental therapeutics.

The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists

D. Sanger, B. Ẑivković, 1989, Journal of psychopharmacology.

Pharmacological and Behavioral Profile of Alpidem as an Anxiolytic

G. Perrault, D. Sanger, K. Lloyd, 1990, Pharmacopsychiatry.

GABA Theory of Depression and Antidepressant Drug Action

B. Scatton, K. Lloyd, G. Bartholini, 1989 .

GABA Receptors, Depression and Antidepressant Drug Action

B. Scatton, P. Morselli, K. Lloyd, 1987 .

Discriminative stimulus properties of chlordiazepoxide and zolpidem. Agonist and antagonist effects of CGS 9896 and ZK 91296

D. Sanger, B. Ẑivković, 1987, Neuropharmacology.

The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials

B. Scatton, P. Worms, P. Morselli, 1983, Pharmacology Biochemistry and Behavior.

Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.

G. Perrault, D. Sanger, E. Morel, 1992, The Journal of pharmacology and experimental therapeutics.

Investigation of the development of tolerance to the actions of zolpidem and midazolam

D. Sanger, B. Zivkovic, B. Ẑivković, 1987, Neuropharmacology.

Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.

Y. Claustre, D. Fage, B. Scatton, 1985, The Journal of pharmacology and experimental therapeutics.

Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics.

G. Perrault, D. Sanger, B. Zivkovic, 1990, European journal of pharmacology.

Further behavioural evidence for the selective sedative action of zolpidem

D. Sanger, B. Zivkovic, B. Ẑivković, 1988, Neuropharmacology.

In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.

G. Perrault, B. Scatton, A. Dubois, 1988, The Journal of pharmacology and experimental therapeutics.

gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.

R. Tissot, J. Constantinidis, B. Scatton, 1982, The Journal of pharmacology and experimental therapeutics.

Pharmaceutical compositions containing nicotine and their application into tobacco weaning

B. Scatton, S. Jegham, P. George, 1999 .

Involvement of 3′,5′-cyclic adenosine monophosphate in the increase of tyrosine hydroxylase activity elicited by cold exposure

A. Guidotti, E. Costa, R. Pfeiffer, 1973, Naunyn-Schmiedeberg's Archives of Pharmacology.

Solid‐Phase Radioimmunoassay for Substance P

A. Oblin, B. Zivkovic, B. Ẑivković, 1983, Journal of neurochemistry.

The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure

D. J. Sanger, E. Morel, G. Perrault, 1987, Physiology & Behavior.

Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic

D. Sanger, B. Zivkovic, B. Ẑivković, 2005, Psychopharmacology.

Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide.

D. Sanger, D. Joly, B. Ẑivković, 1985, The Journal of pharmacology and experimental therapeutics.

The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic

D. Sanger, B. Zivkovic, B. Ẑivković, 2004, Psychopharmacology.

Two-way avoidance and acute shock stress induced alterations of regional noradrenergic, dopaminergic and serotonergic activity in Roman high- and low-avoidance rats.

J. Martin, P. Driscoll, J. Dědek, 1983, Life sciences.

Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice

G. Perrault, D. Sanger, E. Morel, 1992, Pharmacology Biochemistry and Behavior.

Lack of involvement of α2-adrenoceptors in the regulation of striatal dopaminergic transmission

B. Scatton, B. Zivkovic, J. Dědek, 1983 .

Specificity within the GABAA receptor supramolecular complex: A consideration of the new ω 1-receptor selective imidazopyridine hypnotic zolpidem

K. Lloyd, K. G. Lloyd, B. Zivkovic, 1988, Pharmacology Biochemistry and Behavior.

Lack of involvement of alpha 2-adrenoceptors in the regulation of striatal dopaminergic transmission.

B. Scatton, J. Dědek, B. Ẑivković, 1983, European journal of pharmacology.

Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat.

Y. Claustre, B. Scatton, K. Lloyd, 1987, The Journal of pharmacology and experimental therapeutics.

Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.

D. Sanger, K. Lloyd, G. Bartholini, 1987, The Journal of pharmacology and experimental therapeutics.

Neurochemical Study of the Cerebrospinal Fluid

B. Zivkovic, M. Bulat, B. Ẑivković, 1978 .

Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.

A. Guidotti, E. Costa, B. Zivkovic, 1975, The Journal of pharmacology and experimental therapeutics.

Concentrations of Putative Neurovascular Transmitters in Major Cerebral Arteries and Small Pial Vessels of Various Species

D. Duverger, E. Mackenzie, L. Rouquier, 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Effects of neuroleptics on striatal tyrosine hydroxylase: changes in affinity for the pteridine cofactor

A. Guidotti, E. Costa, B. Zivkovic, 1974 .

Amphetamine enhances latent dopaminergic neurotransmission in the rat striatum

S. Z. Langer, S. Arbilla, R. Cantrill, 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

Increase of tryptophan hydroxylase activity elicited by reserpine.

A. Guidotti, E. Costa, B. Zivkovic, 1973, Brain research.

Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.

A. Guidotti, B. Zivkovic, B. Ẑivković, 1974, Brain research.

Influence of GABA mimetics and lithium on biochemical manifestations of striatal dopamine target cell hypersensitivity.

D. Fage, A. Oblin, B. Scatton, 1985, Psychopharmacology. Supplementum.

Penetration of 5‐hydroxyindoleacetic acid across the blood‐cerebrospinal fluid barrier

M. Bulat, B. Ẑivković, 1973, The Journal of pharmacy and pharmacology.

Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra

A. Oblin, G. Bartholini, B. Ẑivković, 1987, Brain Research.

Non-benzodiazepine anxiolytics: Potential activity of phenylpiperazines without 3H-diazepam displacing action

H. Schoemaker, B. Scatton, P. Manoury, 1985, Pharmacology Biochemistry and Behavior.

Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.

A. Oblin, G. Bartholini, B. Zivkovic, 1985, European journal of pharmacology.

The regulation of the kinetic state of striatal tyrosine hydroxylase and the role of postsynaptic dopamine receptors

A. Guidotti, E. Costa, B. Zivkovic, 1975, Brain Research.

The regulation of striatal tyrosine hydroxylase

A. Guidotti, E. Costa, B. Zivkovic, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Proposal for an ‘omega modulatory site’ nomenclature to replace the benzodiazepine receptor denomination

B. Scatton, S. Z. Langer, S. Arbilla, 1991, European Neuropsychopharmacology.

Alpidem, an omega-1 receptor-selective partial agonist: a new approach to anxiety treatment

G. Perrault, D. Sanger, S. Z. Langer, 1991, European Neuropsychopharmacology.

[3H]haloperidol labels brain dopamine receptors after its injection into the internal carotid artery of the rat

G. Bartholini, B. Zivkovic, Antonio D'Ambrosio, 1982, Brain Research.

Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice

D. Sanger, D. Joly, B. Zivkovic, 2004, Psychopharmacology.

The interaction between zolpidem and beta-CMC: a clue to the identification of receptor sites involved in the sedative effect of zolpidem.

G. Perrault, D. Sanger, B. Zivkovic, 1988, European journal of pharmacology.

[Contribution of zolpidem in the management of sleep disorders].

G. Perrault, P. Robert, J. Lavoisy, 1992, L'Encephale.

Interaction of GABA mimetics with nigro-striatal dopamine neurons

B. Scatton, P. Worms, K. Lloyd, 1979, Brain Research Bulletin.

DOPAMINE NEURON ACTIVITY: EFFECT OF SL 76 002, A NEW GABA MIMETIC CANDIDATE

B. Scatton, P. Worms, K. Lloyd, 1979 .

Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.

B. Scatton, G. Bartholini, B. Ẑivković, 1980, Advances in biochemical psychopharmacology.

A. Oblin, B. Scatton, P. Worms, 1983 .

Differential influence of GABA-ergic agents on dopamine metabolism in extrapyramidal and limbic systems of the rat

B. Scatton, G. Bartholini, B. Ẑivković, 1980, Brain Research Bulletin.

Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.

B. Scatton, P. Worms, K. Lloyd, 1981, Advances in biochemical psychopharmacology.

[3H]imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotonergic neurons.

Y. Agid, M. Ruberg, B. Scatton, 1983, European journal of pharmacology.

Short- and long-term regulation of tyrosine hydroxylase.

A. Guidotti, E. Costa, B. Zivkovic, 1974, Advances in biochemical psychopharmacology.

Metalloendopeptidase (EC 3.4.24.11) but not angiotensin converting enzyme is involved in the inactivation of substance P by synaptic membranes of the rat substantia nigra.

A. Oblin, B. Ẑivković, M. J. Danse, 1989, Life sciences.

Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors

D. Sanger, B. Zivkovic, B. Ẑivković, 1992, Neuropharmacology.

Degradation of substance P by membrane peptidases in the rat substantia nigra: Effect of selective inhibitors

A. Oblin, B. Ẑivković, M. J. Danse, 1988, Neuroscience Letters.